I thought the new biomarker was supposed to significantly improve the multivariant numbers for Lympro. The numbers on that abstract seemed very similar to what the LP002 numbers were last October. They said the final numbers would be ready by the presentation, yet we haven't been given any further updates.

For Gerald to allow the stock price to go this low and to not have anything more to say.....is inexplicable! He says nothing negative has happened, yet all our stock values have shrunk 30% in the last 3 weeks!

He needs to do his job and fulfill his promises or step down immediately!!